Biotech companies quickly entering generic market for biotech drugs known as biosimilars as federal officials push to contain health care spending. Momenta Pharmaceuticals, Biogen Idec,  and  Amgen have started separate ventures to develop, make, and  market generic biotech drugs.

Biotech companies quickly entering generic market for biotech drugs known as biosimilars as federal officials push to contain health care spending. Momenta Pharmaceuticals, Biogen Idec, and Amgen have started separate ventures to develop, make, and market generic biotech drugs.

5 notes

Show

  1. knowsource posted this